Pipeline Products
Innocoll has developed and manufactured a range of pharmaceutical products and medical devices using our well established, proprietary collagen-based technologies, CollaRx®, CollaFilm®, CollaPress™ and LiquiColl®.
We have approved commercial products on the market in both Europe and the US, and internationally, as well as a broad portfolio of pipeline products at advanced stages of clinical development. Our pipeline products include:
|
PRODUCT |
DESCRIPTION |
|
|
Cogenzia is a biodegradable and fully resorbable gentamicin-collagen sponge formulated and manufactured using Innocoll's proprietary collagen-based drug delivery technology, CollaRx®. |
|
XaraColl is a surgical implant for the sustained delivery of bupivacaine hydrochloride, a locally-acting anesthetic, for the management of postoperative pain.
|
|
|
Innocoll's CollaRx® Gentamicin Surgical Implant is currently in phase III clinical development in the US for the prevention of surgical site infections (SSIs) in patients at risk of infection. |
|
|
Durieva is being developed for dura reconstruction as a temporary dura replacement and biomatrix for dura regeneration. |
New Product & Technology Developments
Innocoll is currently developing 2nd and 3rd generation products by incorporating additional or alternative active ingredients into its various collagen-based technology matrices for implantation and topical application.
For more information on this product, or to discuss partnership opportunities, please contact our business development team.